Griffin Securities Upgrades Unilife Corporation (UNIS) to Buy on Amgen Deal
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- S&P 500 ends higher as CoreWeave results fuel AI optimism
- Oil prices edge up as investors weigh US-Iran talks deadlock against lower demand
- CoreWeave soars after fifth straight quarter of record revenue, raised guide
- Four key things investors will watch in Nvidia's earnings next week
- Silver could surge to $90 as investment demand takes over, Citi says
- After-Hours Movers: CSCO, COHR, HLIT, CBRS, STUB, ENS
- After-Hours Movers: CRWV, NBIS, SMCI, LITE, CAVA, HRB
- After-Hours Movers: P, RIOT, BW, RKLB, HIMS, UPWK
- After-Hours Movers: TEAM, NET, TWLO, DOCS, FROG, DV, TTD, ABNB, DKNG, SG, RKT
- After-Hours Stock Movers: WDC, SNDK, FIG, APP, HUBS, SOUN, DASH, XYZ, Z, FLNC
Piper Jaffray 'Encouraged' by Unilife's (UNFI) Amgen Agreement
January 4, 2016 9:40 AM ESTPiper Jaffray analyst Charles Duncan reiterated an Overweight rating and $5 price target on Unilife Corporation (NASDAQ: UNIS) following the exclusivity agreement with Amgen.
Under the agreement, Amgen will provide a $15M deposit and is granted consideration for the worldwide license on each of Unilife's... More
Unilife Corp. (UNIS) Enters Exclusivity Agreement with Amgen (AMGN)
January 4, 2016 7:13 AM ESTUnilife Corp. (NASDAQ: UNIS) disclosed in an SEC filing:
On December 31, 2015, Unilife Corporation (the Company or we) entered into an exclusivity agreement (the Agreement) with Amgen Inc. (the Counterparty). The Agreement was entered into in connection with the previously announced review by the Company of potential strategic alternatives, including a strategic partnership with one or more parties or the licensing of some of the Companys proprietary technologies (a Potential Transaction). Pursuant to the Agreement, we agreed to negotiate a Potential Transaction exclusively with the Counterparty until the earlier of January 31, 2016 or the Counterparty notifies... More
